Unknown

Dataset Information

0

Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma.


ABSTRACT: Esophageal squamous cell carcinoma (ESCC) remains one of the leading causes of cancer-related mortality around the world. The identification of novel serum biomarkers is required for early detection of ESCC. This study was designed to elucidate whether autoantibodies against STIP1 could be a diagnostic biomarker in ESCC. An enzyme-linked immunosorbent assay was performed to detect serum levels of STIP1 autoantibodies in a training cohort (148 ESCC patients and 111 controls) and a validation cohort (60 ESCC patients and 40 controls). Mann-Whitney's U test showed that ESCC patients in two cohorts have higher levels of autoantibodies against STIP1 when compared to controls (P < 0.001). According to receiver operating characteristic analysis, the sensitivity, specificity, and area under the curve (AUC) of autoantibodies against STIP1 in ESCC were 41.9%, 90.1%, and 0.682 in the training cohort and 40.0%, 92.5%, and 0.710 in the validation cohort, respectively. Moreover, detection of autoantibodies against STIP1 could discriminate early-stage ESCC patients from controls, with sensitivity, specificity, and AUC of 35.7%, 90.1%, and 0.684 in the training cohort and 38.5%, 92.5%, and 0.756 in the validation cohort, respectively. Our findings indicated that autoantibodies against STIP1 might be a useful biomarker for early-stage ESCC detection.

SUBMITTER: Xu YW 

PROVIDER: S-EPMC5567451 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma.

Xu Yi-Wei YW   Liu Can-Tong CT   Huang Xin-Yi XY   Huang Li-Sheng LS   Luo Yu-Hao YH   Hong Chao-Qun CQ   Guo Hai-Peng HP   Xu Li-Yan LY   Peng Yu-Hui YH   Li En-Min EM  

Disease markers 20170809


Esophageal squamous cell carcinoma (ESCC) remains one of the leading causes of cancer-related mortality around the world. The identification of novel serum biomarkers is required for early detection of ESCC. This study was designed to elucidate whether autoantibodies against STIP1 could be a diagnostic biomarker in ESCC. An enzyme-linked immunosorbent assay was performed to detect serum levels of STIP1 autoantibodies in a training cohort (148 ESCC patients and 111 controls) and a validation coho  ...[more]

Similar Datasets

| S-EPMC3068276 | biostudies-literature
| S-EPMC5337388 | biostudies-literature
| S-EPMC3887578 | biostudies-literature
| S-EPMC4944864 | biostudies-other
| S-EPMC7581083 | biostudies-literature
| S-EPMC5969074 | biostudies-literature
| S-EPMC5470983 | biostudies-literature
| S-EPMC5753462 | biostudies-literature
| S-EPMC2942852 | biostudies-other
| S-EPMC6117325 | biostudies-literature